G. Steven Bova
George Steven Bova is an American physician-scientist, pathologist, and researcher best known for his work on the genomics and evolutionary history of metastatic prostate cancer, biomedical research informatics, and translational cancer medicine. He is Emeritus Professor of Personalized Cancer Medicine at Tampere University (Finland), founder and CEO of ''Orbican Systems'' (U.S. & Finland), and founder of the research informatics company ''BioFortis'' (Labmatrix). As of 2025, Bova has an h-index of 76 according to Google Scholar. Provided by Wikipedia-
1by Qing Kay Li, Jing Chen, Yingwei Hu, Naseruddin Höti, Tung-Shing Mamie Lih, Stefani N. Thomas, Li Chen, Sujayita Roy, Alan Meeker, Punit Shah, Lijun Chen, G. Steven Bova, Bai Zhang, Hui ZhangGet full text
Published 2021
article -
2by Sam Behjati, Gunes Gundem, David C. Wedge, Nicola D. Roberts, Patrick S. Tarpey, Susanna L. Cooke, Peter Van Loo, Ludmil B. Alexandrov, Manasa Ramakrishna, Helen Davies, Serena Nik-Zainal, Claire Hardy, Calli Latimer, Keiran M. Raine, Lucy Stebbings, Andy Menzies, David Jones, Rebecca Shepherd, Adam P. Butler, Jon W. Teague, Mette Jorgensen, Bhavisha Khatri, Nischalan Pillay, Adam Shlien, P. Andrew Futreal, Christophe Badie, ICGC Prostate Group, Ultan McDermott, G. Steven Bova, Andrea L. Richardson, Adrienne M. Flanagan, Michael R. Stratton, Peter J. CampbellGet full text
Published 2016
article